ストックスクリーナーアプリを入手
8.10
1.70%
-0.14
プレマーケット:
8.20
0.10
+1.23%
前日終値:
$8.24
開ける：
$8.17
24時間の取引高:
6.39M
Relative Volume:
1.32
時価総額：
$4.02B
収益：
$4.45B
当期純損益:
$205.00M
株価収益率:
20.25
EPS:
0.4
ネットキャッシュフロー:
$372.00M
1週間 パフォーマンス:
-13.65%
1か月 パフォーマンス:
-22.41%
6か月 パフォーマンス:
-38.91%
1年 パフォーマンス:
-40.62%
1日の値動き範囲:
$8.09
$8.43
1週間の範囲:
$8.09
$9.15
52週間の値動き範囲:
$8.03
$18.80
Elanco Animal Health Inc Stock (ELAN) Company Profile
名前
Elanco Animal Health Inc
セクター
電話
877-352-6261
住所
2500 INNOVATION WAY, GREENFIELD
ELAN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
8.10 | 4.02B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
146.76 | 65.46B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.65 | 46.11B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.16 | 45.85B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.43 | 15.39B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
285.19 | 12.81B | 2.76B | 1.11B | 898.10M | 22.77 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-09 | 開始されました | UBS | Buy |
| 2024-12-02 | 開始されました | Leerink Partners | Market Perform |
| 2024-09-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | アップグレード | Stifel | Hold → Buy |
| 2023-12-19 | 開始されました | Jefferies | Buy |
| 2023-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | 開始されました | Exane BNP Paribas | Outperform |
| 2023-04-20 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-08-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-07-21 | ダウングレード | Goldman | Buy → Sell |
| 2022-07-12 | 開始されました | Piper Sandler | Neutral |
| 2021-11-18 | 開始されました | Morgan Stanley | Overweight |
| 2021-10-28 | ダウングレード | Stifel | Buy → Hold |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-06-15 | アップグレード | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | アップグレード | Barclays | Underweight → Equal Weight |
| 2021-05-11 | アップグレード | Gabelli & Co | Hold → Buy |
| 2021-04-15 | 開始されました | Stifel | Buy |
| 2021-03-22 | ダウングレード | Gabelli & Co | Buy → Hold |
| 2021-02-26 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | ダウングレード | Argus | Buy → Hold |
| 2020-11-09 | ダウングレード | Barclays | Overweight → Underweight |
| 2020-08-20 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | 再開されました | Credit Suisse | Neutral |
| 2020-08-04 | 再開されました | Goldman | Buy |
| 2020-07-27 | ダウングレード | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | 開始されました | Raymond James | Mkt Perform |
| 2019-12-19 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | 開始されました | Barclays | Overweight |
| 2019-08-26 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | アップグレード | UBS | Sell → Neutral |
| 2019-05-23 | 開始されました | Guggenheim | Neutral |
| 2019-03-18 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | 再開されました | Morgan Stanley | Equal-Weight |
| 2019-02-12 | 開始されました | William Blair | Mkt Perform |
| 2019-01-23 | 開始されました | UBS | Sell |
| 2019-01-15 | 開始されました | Argus | Buy |
| 2018-10-15 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Elanco Animal Health Inc (ELAN) 最新ニュース
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Sold by Alliancebernstein L.P. - Defense World
LPL Financial LLC Raises Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Stockholders to Connect - markets.businessinsider.com
Veterinary Medicine Market to Witness Remarkable Growth with Ceva, Zoetis, Elanco, Chanelle Pharma Group - openPR.com
Elanco (ELAN) Sees Price Target Cut by Morgan Stanley to $10 | ELAN Stock News - GuruFocus
US FDA approves Elanco's treatment for parasitic infections in dogs - AOL.com
Elanco Animal Health (NYSE:ELAN) Given New $13.00 Price Target at Stifel Nicolaus - Defense World
Stifel Adjusts Elanco (ELAN) Price Target, Maintains Buy Rating - GuruFocus
Franklin Resources Inc. Has $1.87 Million Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
‘Let the bad news travel as fast as the good news’: 5 questions for Elanco Animal Health’s Jeff Simmons - Semafor
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Stockholders to Learn More About the Investigation - markets.businessinsider.com
Elanco Animal Health (ELAN) Soars 12.6%: Is Further Upside Left in the Stock? - Yahoo Finance
Companion Animal Vaccine Marketto Register for Rapid Growth, - openPR.com
Elanco Confirms Date and Conference Call for First Quarter 2025 Financial Results Announcement | ELAN Stock News - GuruFocus
Elanco to Reveal Q1 2025 Financial Performance: Key Details for Investors - Stock Titan
Pets External Medicine Market Still Has Room To Grow: Zoetis, Elanco, Merck Animal Health, Bayer Animal Health - openPR.com
American Century Companies Inc. Acquires 2,280 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Elanco enters research agreement to address CKD in cats and explore lifespan extension in pets - DVM360
Veterinary Oncology Market Is Booming Worldwide 2025-2032 | - openPR.com
Commonwealth Equity Services LLC Sells 9,801 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Investors to Inquire about Securities Investigation - markets.businessinsider.com
Elanco Partners With SASH To Support Blood Donor Program - ACCESS Newswire
2025-04-08 | Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Investors to Inquire about Securities Investigation | NYSE:ELAN | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Reach Out - ACCESS Newswire
HighTower Advisors LLC Reduces Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Elanco Expands Huningue Site to Support Latest Pet Health Innovations - ACCESS Newswire
Elanco Breaks Ground for Animal Health in Huningue, France - 3BL Media
Veterinary Clostridium Vaccine Market Detailed Industry - openPR.com
Dogs Vaccines Market Generated Opportunities, Future Scope - openPR.com
ELAN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Examination into Elanco Animal Health Incorporated and Encourages Investors to Contact the Firm Today! - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Shareholders to Learn More About the Investigation - markets.businessinsider.com
Elanco stock hits 52-week low at $10.02 amid market challenges - Investing.com
Veterinary Oncology Market Future Business Opportunities - openPR.com
FDA Approval of Elanco Cow Ammonia Drug Upheld in Federal Court - Bloomberg Law News
ELAN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Shareholders of Elanco Animal Health Incorporated Should Contact Levi & Korsinsky Before December 6, 2024 to Discuss Your RightsELAN - ACCESS Newswire
ELAN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ELAN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
FDA Beats Challenge To Approval Of Elanco's Cattle Gas Drug - Law360
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
Elanco wins dismissal of Tevra Brands' US antitrust complaint - MLex
Elanco Animal Health: Even Cheaper, Still Not A Buy - Seeking Alpha
Dogs Vaccines Market Size, Industry Shares, Global Growth - openPR.com
Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Shareholders to Inquire about Securities Investigation - markets.businessinsider.com
Corient Private Wealth LLC Decreases Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Is Elanco Animal Health (ELAN) About to Explode? - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Connect - Markets Insider
SEC Form DEFA14A filed by Elanco Animal Health Incorporated - Quantisnow
SEC Form DEF 14A filed by Elanco Animal Health Incorporated - Quantisnow
Elanco Animal Health Inc (ELAN) 財務データ
収益
当期純利益
現金流量
EPS
Elanco Animal Health Inc (ELAN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Kurzius Lawrence Erik | Director |
Mar 11 '25 |
Buy |
10.20 |
10,000 |
102,000 |
111,459 |
| HOOVER R DAVID | Director |
Mar 05 '25 |
Buy |
10.90 |
25,000 |
272,558 |
210,000 |
| Harrington Michael J | Director |
Aug 22 '24 |
Buy |
14.85 |
3,500 |
51,974 |
81,094 |
| Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR |
Aug 12 '24 |
Buy |
13.01 |
100,000 |
1,300,610 |
145,000 |
| DOYLE WILLIAM F | Director |
May 21 '24 |
Buy |
16.98 |
15,000 |
254,700 |
76,330 |
2.65%
4.10%
大文字化:
|
ボリューム (24 時間):